Non-Hodgkin Lymphoma PBMC

All filters

Format

Format

Format
Volume / Size

Volume / Size

Volume / Size
Condition

Condition

Condition

Start typing to see matching condition.

Donor Demographics

Donor Demographics

Gender
Age Range
Race / Ethnicity

Start typing to see matching race / ethnicity.

Country of Collection
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot #

Start typing to see matching lot #.

Patient ID

Start typing to see matching patient id.

26 lots match
26 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Non-Hodgkin Lymphoma (NHL) PBMC 78864 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Vincristine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212072PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo27.28NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78863 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Vincristine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212071PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo27.28NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78866 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Vincristine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212074PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo27.28NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78865 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Vincristine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212073PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo27.28NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78879 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Doxorubicin Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212088PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo23.63NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78881 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Doxorubicin Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212090PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo23.63NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78880 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Doxorubicin Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212089PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo23.63NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78883 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Doxorubicin Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212092PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo23.63NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78882 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Doxorubicin Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212091PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo23.63NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78885 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Doxorubicin Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212094PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo23.63NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78884 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cyclophosphamide, Doxorubicin Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212093PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo23.63NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78899 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Rituximab, Bendamustine, Dexamethasone Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212119PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo26.31NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78898 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Rituximab, Bendamustine, Dexamethasone Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212118PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo26.31NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78900 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Rituximab, Bendamustine, Dexamethasone Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212120PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo26.31NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78902 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Rituximab, Bendamustine, Dexamethasone Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212122PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo26.31NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78901 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Rituximab, Bendamustine, Dexamethasone Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212121PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo26.31NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78903 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Rituximab, Bendamustine, Dexamethasone Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212123PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo26.31NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78916 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cisplatin, Gemcitabine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212142PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo29.93NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78918 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cisplatin, Gemcitabine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212144PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo29.93NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78917 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cisplatin, Gemcitabine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212143PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo29.93NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78920 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cisplatin, Gemcitabine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212146PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo29.93NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 78919 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Cisplatin, Gemcitabine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212145PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo29.93NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 79359 — Female 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Rituximab, Cyclophosphamide, Vincristine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212194PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo31.17NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 79358 — Female 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Rituximab, Cyclophosphamide, Vincristine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212193PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo31.17NoNoNoStoredIn Stock
$1,750
Non-Hodgkin Lymphoma (NHL) PBMC 79361 — Female 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Rituximab, Cyclophosphamide, Vincristine Non-Hodgkin Lymphoma (NHL) Ukraine 2026 — — — — — — — — — 212196PBMC10M cellsNon-Hodgkin Lymphoma (NHL)Non-Hodgkins LymphomaNo31.17NoNoNoStoredIn Stock
$1,750

Showing 1–25 of 26 lots

About Non-Hodgkin Lymphoma PBMC

Non-Hodgkin Lymphoma PBMC are sourced from consented donors with documented non-hodgkin lymphoma (NHL). These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Non-Hodgkin Lymphoma (NHL) research
  • Immune-cell phenotyping
  • Cellular functional assays
  • Single-cell and bulk transcriptomics
  • Drug-response research

Product Features

  • Peripheral blood mononuclear cells
  • Donor condition: Non-Hodgkin Lymphoma (NHL)
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Non-Hodgkin Lymphoma PBMC with normal donor samples for comparison

Healthy Donor PBMCs

733 In Stock
Screened normal donors · Cryopreserved · Starting at $205
View Inventory

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information